Abstract:Targeted anticancer drugs block cancer cell growth by interfering with specific signaling pathways vital to carcinogenesis and tumor growth rather than harming all rapidly dividing cells as in cytotoxic chemotherapy. The Response Evaluation Criteria in Solid Tumor (RECIST) system has been used to assess tumor response to therapy via changes in the size of target lesions as measured by calipers, conventional anatomically based imaging modalities such as computed tomography (CT), and magnetic resonance imaging (MRI), and other imaging methods. However, RECIST is sometimes inaccurate in assessing the efficacy of targeted therapy drugs because of the poor correlation between tumor size and treatment-induced tumor necrosis or shrinkage. This approach might also result in delayed identification of response when the therapy does confer a reduction in tumor size. Innovative molecular imaging techniques have rapidly gained importance in the dawning era of targeted therapy as they can visualize, characterize, and quantify biological processes at the cellular, subcellular, or even molecular level rather than at the anatomical level. This review summarizes different targeted cell signaling pathways, various molecular imaging techniques, and developed probes. Moreover, the application of molecular imaging for evaluating treatment response and related clinical outcome is also systematically outlined. In the future, more attention should be paid to promoting the clinical translation of molecular imaging in evaluating the sensitivity to targeted therapy with biocompatible probes. In particular, multimodal imaging technologies incorporating advanced artificial intelligence should be developed to comprehensively and accurately assess cancer-targeted therapy, in addition to RECIST-based methods.

Application of Optical Molecular Imaging for the Development of Anticancer Drugs

Application of Molecular Imaging in Drug Development of Cancer

Optical Molecular Imaging for Early Tumor Diagnosis and Drug Development

Preface for the Special Issue on Analysis of Drug or Drug Targets by Molecular Imaging

Optical Molecular Imaging in Drug Discovery and Clinical Development

Applications of Molecular Imaging in Drug Discovery and Development

New optical molecular imaging systems.

Targeted Optical Imaging Agents in Cancer: Focus on Clinical Applications

New in vivo optical molecular imaging modalities

Optical imaging in drug discovery and diagnostic applications

Optical molecular imaging guided surgical navigation for cancers

Molecular Imaging for Cancer Immunotherapy: Seeing is Believing

Optical Molecular Imaging for Tumor Detection and Image-Guided Surgery.

Applications of Molecular MRI and Optical Imaging in Cancer

Basic research and clinical application of optical molecular imaging in breast cancer

Optical probes and the applications in multimodality imaging.

Optical molecular imaging for systems biology: from molecule to organism

Advances on interventional molecular imaging

Recent Advances in Optical Imaging of Biomarkers in Vivo

Molecular and functional imaging in cancer-targeted therapy: current applications and future directions

In Vitro and in Vivo Imaging Applications in Tumor Targeting of Drug Delivery Systems